BOSTON--(BUSINESS WIRE)--Foundation Medicine today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing ... .
BOSTON - May 23, 2025 - FoundationMedicine, Inc., a genomics company committed to transforming cancer care, today announced that it has expanded its immunohistochemistry (IHC) test offerings to ...
IRVING, Texas, May 12, 2025 /PRNewswire/ -- Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing as ...